The Middle East Veterinary Vaccine Market is poised for steady growth, with a projected market size of USD 627.1 million in 2023. The market is expected to expand at a CAGR of 4% through 2033, reaching a valuation of USD 973.8 million by the end of the forecast period.
Increasing awareness regarding animal health and the growing demand for veterinary care across the region are key factors driving the growth of the veterinary vaccine market. With a rise in both companion animal ownership and livestock farming, the need for effective vaccines to prevent diseases and ensure animal well-being is becoming more prominent.
Key Trends Influencing Demand through 2033
- The Middle East is investing significant resources in biotechnology and research, supporting innovation in veterinary vaccine manufacturing. This investment strengthens the industry’s capabilities and raises the region’s profile in the global biotech industry.
- Significant zoonotic disease outbreaks, such as MERS, have occurred in the region. Recognizing the significant health and economic ramifications, the Middle East prioritizes animal immunization to protect both animal and human health.
- The Middle East has a thriving livestock industry that caters to the expanding demand for meat, dairy, and poultry products. Veterinary vaccinations are critical for minimizing illness risks and guaranteeing these animals’ health and production.
- The region quickly embraces digital technologies and data-driven solutions for disease tracking, animal health surveillance, and optimizing vaccine distribution. This digital shift improves efficiency and effectiveness across the veterinary vaccine value chain.
- The Middle East has a large population of camels, which play a substantial role in the region’s culture and commerce. As a result, there is a unique tendency toward creating camel-specific vaccines to serve the camel farming and racing businesses.
- Advanced data analytics and predictive modeling are being used to forecast illness outbreaks, enabling preventive immunization efforts and reducing the region’s economic burden from diseases.
- To increase animal health and alleviate poverty, certain Middle Eastern governments are working to ensure equitable access to veterinary vaccines for underprivileged and nomadic people, particularly in distant places.
Key Market Insights:
- Market Valuation: Projected to reach US$ 973.8 million by 2033, up from US$ 627.1 million in 2023.
- CAGR: Expected to grow at a 4% CAGR during the forecast period.
- Growth Drivers: Increasing demand for animal health products, rising awareness of the benefits of vaccination, and growing investments in veterinary healthcare infrastructure.
- Market Trends: Growing focus on vaccine development for both companion animals and livestock to combat emerging diseases and enhance productivity.
The veterinary vaccine market in the Middle East is set to thrive, driven by the rising need for preventive healthcare in animals and the continued advancement in vaccine technology. As the region’s veterinary care sector expands, the demand for innovative and effective vaccines is expected to increase significantly over the next decade.
Competitive Landscape in the Middle East Veterinary Vaccine Industry
The Middle East veterinary vaccines industry’s competitive environment is defined by a broad array of players and entities, each of which contributes to the sector’s growth and development. Multinational pharmaceutical conglomerates like Zoetis, MSD Animal Health (Merck Animal Health in the United States and Canada), and Boehringer Ingelheim have a prominent presence in the region. These firms provide a wide range of vaccines, building on established brand awareness using their global reach and substantial research capabilities. Key players provide complete solutions to a wide range of animal health issues across the Middle East.
Recent Developments in the Middle East Veterinary Vaccine Industry
- Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments at the 2023 Grand Challenges Annual Meeting in October 2023 to advance access to mRNA research and vaccine manufacturing technology. This will support low- and middle-income countries’ (LMICs’) capacity to develop large-scale, high-quality, lifesaving vaccines. The decision builds on the foundation’s more than 20 years of experience working with vaccine producers in LMICs, as well as the chance to use recent scientific discoveries to develop low-cost, high-quality health tools that reach more people throughout the world.
- Kansas State University’s College of Veterinary Medicine announced the establishment of the new Center on Vaccine Evaluation and Alternatives for Antimicrobials, or CVEAA, in July 2023 to promote animal vaccine development and use.
A Full Report Analysis
Key Players in the Middle East Veterinary Vaccine Industry
- JOVAC
- Bioveta, Inc.
- Intervac Pvt. Ltd.
- Zoetis
- Elanco
- Merial
- Merck & Co. Inc.
- Bayer Pharma AG
- Ceva
- Boehringer Ingelheim
- MSD Animal Health
Middle East Veterinary Vaccine Industry Segmentation
By Vaccine:
- Attenuated Live Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Others
By Animal:
- Companion Animals
- Canine
- Avian
- Feline
- Livestock Animals
- Aquatic
- Bovine
- Porcine
- Small Ruminant
- Poultry
- Equine
By Disease Indication:
- Foot and Mouth Disease
- Newcastle Disease
- PPRS
- Canine Parvovirus
- Brucellosis
- Avian Influenza
- Others
By End User:
- Hospital Pharmacies
- Veterinary Clinics
- Private Veterinary Pharmacies
- Others
By Country:
- UAE
- KSA
- Turkey
- Jordan
- Sudan
- Egypt
- Rest of MEA
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
